Augmedix (AUGX)
(Delayed Data from NSDQ)
$0.92 USD
+0.01 (0.94%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $0.92 0.00 (0.37%) 7:58 PM ET
2-Buy of 5 2
C Value D Growth A Momentum C VGM
Augmedix, Inc. (AUGX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$3.75 | $7.00 | $1.50 | 312.09% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for Augmedix, Inc. comes to $3.75. The forecasts range from a low of $1.50 to a high of $7.00. The average price target represents an increase of 312.09% from the last closing price of $0.91.
Analyst Price Targets (4 )
Broker Rating
Augmedix, Inc. currently has an average brokerage recommendation (ABR) of 1.67 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by six brokerage firms. The current ABR compares to an ABR of 1.67 a month ago based on six recommendations.
Of the six recommendations deriving the current ABR, four are Strong Buy, representing 66.67% of all recommendations. A month ago, Strong Buy represented 66.67%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 6 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.67 | 1.67 | 1.67 | 1.67 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
5/14/2024 | Evercore Partners | Elizabeth Anderson | Strong Buy | Hold |
5/14/2024 | Maxim Group | Allen Klee | Strong Buy | Hold |
4/4/2024 | Lake Street Capital Markets | Brooks G O'Neil | Strong Buy | Strong Buy |
4/3/2024 | B. Riley Securities | Yuan Zhi | Strong Buy | Strong Buy |
3/12/2024 | William Blair | Ryan S Daniels | Strong Buy | Strong Buy |
2/12/2024 | The Benchmark Company | William Sutherland | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.67 |
ABR (Last week) | 1.67 |
# of Recs in ABR | 6 |
Average Target Price | $3.75 |
LT Growth Rate | NA |
Industry | Medical Info Systems |
Industry Rank by ABR | 70 of 252 |
Current Quarter EPS Est: | -0.12 |